Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

297 Views

Poster Session: Antimicrobial Novel Agents

1697 - Dose-response Studies of the Novel Bacterial Leucyl-tRNA Synthetase Inhibitor, **Epetraborole, in the Intracellular Hollow Fiber System Model of Mycobacterium avium complex Lung Disease**

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

MC

Moti Chapagain, MD, PhD

Director
Praedicare Inc.
Dallas, Texas, United States
SA

Shruti Athale, PhD

Associate Director
Praedicare Inc.
Dallas, Texas, United States
JP

Jotam Pasipanodya, MD, PhD

Praedicare Inc.
Dallas, Texas, United States
DH

David Howe, PhD

Praedicare Inc.
Dallas, Texas, United States
MA

MRK Alley, PhD

Head of Biology
AN2 Therapeutics
Menlo Park, California, United States

Presenting Author(s)

Tawanda Gumbo, MD

CEO
Praedicare Inc.
Dallas, Texas, United States